Company: PSTV
Filing Date: 2025-07-21
Form Type: DEF 14A
Source: 0001140361-25-026611
Chunk: 57

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-07-21
Form: DEF 14A
Chunk 57
---
 scope of procedure, which disagreements, if not resolved to BDO USA, P.C.’s satisfaction, would have caused BDO USA, P.C. to make reference to the subject matter of the disagreements in connection with their reports or (ii) reportable events (as defined in Item 304(a)(1)(v) of Regulation S-K under the Exchange Act), except for the material weakness in the Company’s internal control over financial reporting as of the year ended December 31, 2023, as previously disclosed in Item 9A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, stemming from the conclusion that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective at the reasonable assurance level due to a material weakness in our internal control over the application of appropriate accounting principles to significant and unusual grant revenue transactions as of December 31, 2023. The Company provided BDO USA, P.C. with a copy of the current report on Form 8-K (the “Form 8-K”) containing the above disclosure prior to its filing with the SEC and requested that BDO USA, P.C. furnish the Company with a letter addressed to the SEC stating whether BDO USA, P.C. agrees with the statements made by the Company in the Form 8-K and, if not, stating the respects, if any, in which BDO USA, P.C. does not agree with such statements. A copy of the letter from BDO is filed with the Form 8-K as Exhibit 16.1. On July 16, 2025, the Audit Committee approved the engagement of CBIZ CPAs P.C. (“CBIZ”), effective immediately, as the Company’s new independent registered public accounting firm to audit the Company’s consolidated financial statements for the year ending December 31, 2025. During the Company’s two most recent fiscal years and the subsequent interim period through July 16, 2025, neither the Company, nor anyone on its behalf, consulted CBIZ regarding (A) the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company by CBIZ that CBIZ concluded was an important factor considered by the Company in reaching a decision as to any accounting